Viokace is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Nestle Healthcare Nutrition, Inc.. The primary component is Pancrelipase Lipase; Pancrelipase Protease; Pancrelipase Amylase.
| Product ID | 73562-208_58bdb8de-582d-44e6-9b72-8d5a42fdf501 |
| NDC | 73562-208 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Viokace |
| Generic Name | Pancrelipase |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-03-01 |
| Marketing Category | BLA / |
| Application Number | BLA022542 |
| Labeler Name | Nestle Healthcare Nutrition, Inc. |
| Substance Name | PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE; PANCRELIPASE AMYLASE |
| Active Ingredient Strength | 20880 [USP'U]/1; [USP'U]/1; [USP'U]/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2021-03-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 58914-112 | Viokace | Pancrelipase |
| 58914-117 | Viokace | Pancrelipase |
| 0032-1203 | Creon | Pancrelipase |
| 0032-1206 | Creon | Pancrelipase |
| 0032-1212 | Creon | Pancrelipase |
| 0032-1224 | Creon | Pancrelipase |
| 0032-3016 | Creon | Pancrelipase |
| 17856-1206 | Creon | Pancrelipase |
| 17856-1212 | Creon | Pancrelipase |
| 17856-1224 | Creon | Pancrelipase |
| 50458-341 | PANCREAZE | PANCRELIPASE |
| 50458-342 | PANCREAZE | PANCRELIPASE |
| 50458-343 | PANCREAZE | PANCRELIPASE |
| 50458-346 | PANCREAZE | PANCRELIPASE |
| 50458-347 | PANCREAZE | PANCRELIPASE |
| 42865-300 | ZENPEP | pancrelipase |
| 42865-302 | ZENPEP | pancrelipase |
| 42865-303 | ZENPEP | pancrelipase |
| 42865-304 | ZENPEP | pancrelipase |
| 42865-305 | ZENPEP | pancrelipase |
| 42865-306 | ZENPEP | pancrelipase |
| 42865-307 | ZENPEP | pancrelipase |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VIOKACE 77896647 4533794 Live/Registered |
ALLERGAN SALES, LLC 2009-12-18 |